KELOWNA, BC / ACCESSWIRE / December 15, 2017 / Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the “Company” or “Lexaria”), a drug delivery platform innovator, announces a new topical skin cream research and development (“R&D”) program; R&D into nicotine edibles; and updates … Read More
The post Lexaria Bioscience Announces New Research Including Cannabinoid Topical Creams and … appeared first on Dagga Magazine.